Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators

Abstract
Sudden cardiac death is one of the most common and often the first manifestation of coronary heart disease. It is responsible for approximately 50% of all mortality from cardiovascular disease in the Western world.1 The majority of sudden deaths are directly caused by acute ventricular arrhythmia.2 Epidemiological studies indicate that intake of very-long-chain n-3 polyunsaturated fatty acids (omega-3 PUFAs) as present in fish or fish oil is associated with a reduction in cardiovascular mortality.3-7 These observational studies showed a strong relationship between omega-3 PUFAs and sudden death, but not between omega-3 PUFAs and nonfatal heart disease.5,8,9 This is confirmed by the outcome of some clinical trials; in the Diet and Reinfarction Trial (DART),10 consumption of fish or fish oil reduced fatal heart disease by more than 30%, and the open-label Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (GISSI) trial4 found a 45% reduction in sudden death in patients consuming omega-3 PUFAs.

This publication has 0 references indexed in Scilit: